June is Vitiligo Awareness Month. In this video, Seemal R. Desai, MD, Founder and Medical Director of Innovative Dermatology and Clinical Assistant Professor of Dermatology at the University of Texas Southwestern Medical Center in Dallas, TX, and Raj Chovatiya, MD, PhD, Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, IL, discuss on- and off-label uses of ruxolitinib (Opzelura, Incyte) in kids with vitiligo. They also discuss the stigma associated with pediatric vitiligo and offer advice on how to field questions from concerned parents.
